Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12051
PUT
Telos
TLS
$327M
| $25.9K | ﹤0.01% |
10,900
-6,700
| -38% | -$20.5K |
|
12052
Ovid Therapeutics
OVID
$568M
| $25.9K | ﹤0.01% |
83,084
+37,964
| +84% | +$23.3K |
|
12053
PUT
Milestone Pharmaceuticals
MIST
$144M
| $25.7K | ﹤0.01% |
32,100
+15,100
| +89% | +$30K |
|
|
MRDN
12054
PUT
Meridian Holdings Inc
MRDN
$175M
| $25.6K | ﹤0.01% |
1,083
+33
| +3% | +$801 |
|
|
CAPT
12055
DELISTED
Captivision
CAPT
| $25.6K | ﹤0.01% |
+53,939
| New | +$29K |
|
|
STLN
12056
Starling Oncology
STLN
$642M
| $25.5K | ﹤0.01% |
+22,388
| New | +$17.3K |
|
12057
PUT
Paysign
PAYS
$798M
| $25.4K | ﹤0.01% |
+12,000
| New | +$32K |
|
12058
Versus Systems
VS
$7.89M
| $25.2K | ﹤0.01% |
+12,075
| New | +$26.4K |
|
12059
Newegg Commerce
NEGG
$369M
| $25.1K | ﹤0.01% |
4,869
-9,044
| -65% | -$72.7K |
|
|
BPT
12060
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $25.1K | ﹤0.01% |
45,338
-15,660
| -26% | -$8.87K |
|
12061
Ampco-Pittsburgh
AP
$182M
| $24.9K | ﹤0.01% |
11,466
-5,808
| -34% | -$12.8K |
|
12062
CALL
CBAK Energy Technology Ltd
CBAT
$84.2M
| $24.9K | ﹤0.01% |
31,100
-21,500
| -41% | -$19.1K |
|
12063
Modular Medical
MODD
$30.9M
| $24.8K | ﹤0.01% |
+759
| New | +$25.3K |
|
|
ASRT
12064
DELISTED
Assertio
ASRT
| $24.6K | ﹤0.01% |
2,427
+242
| +11% | +$2.88K |
|
12065
Retractable Technologies
RVP
$22M
| $24.4K | ﹤0.01% |
34,638
+14,710
| +74% | +$11.4K |
|
12066
PUT
Chegg
CHGG
$87.9M
| $24.3K | ﹤0.01% |
38,000
-158,200
| -81% | -$196K |
|
12067
Brilliant Earth
BRLT
$21.6M
| $24.2K | ﹤0.01% |
15,287
-16,898
| -53% | -$27.5K |
|
12068
Scilex Holding
SCLX
$39.7M
| $24.1K | ﹤0.01% |
2,772
+629
| +29% | +$7.9K |
|
|
DADA
12069
PUT
DELISTED
Dada Nexus
DADA
| $24.1K | ﹤0.01% |
13,000
-7,500
| -37% | -$12.9K |
|
12070
Verrica Pharmaceuticals
VRCA
$84.9M
| $23.9K | ﹤0.01% |
+5,412
| New | +$35K |
|
12071
CALL
Coherus Oncology
CHRS
$212M
| $23.8K | ﹤0.01% |
29,400
-856,500
| -97% | -$986K |
|
12072
Globavend
GVH
$2.49M
| $23.7K | ﹤0.01% |
+209
| New | +$29.3K |
|
|
ZTEK
12073
Zentek
ZTEK
$76.2M
| $23.7K | ﹤0.01% |
+21,318
| New | +$22.5K |
|
|
RJET
12074
CALL
Republic Airways Holdings
RJET
$897M
| $23.2K | ﹤0.01% |
+1,987
| New | +$34K |
|
|
PWCM
12075
PowerCompute Inc
PWCM
$1.09M
| $23.1K | ﹤0.01% |
+745
| New | +$32.7K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.